We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.96B
1-Year Est. Return 48.96%
This Fund
S&P 500
This Quarter Est. Return
-15.1%
1 Year Est. Return
+48.96%
3 Year Est. Return
+156.47%
5 Year Est. Return
+196.14%
10 Year Est. Return
+689.54%
AUM
$1.29B
AUM Growth
-$350M
Cap. Flow
-$26.9M
Cap. Flow %
-2.09%
Top 10 Hldgs %
26.92%
Holding
2,725
New
403
Increased
995
Reduced
859
Closed
275

Sector Composition

Rank Sector Weight
1 Technology 19.38%
2 Healthcare 15.01%
3 Financials 10.3%
4 Consumer Discretionary 8.01%
5 Communication Services 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTH icon
2226
Astrana Health
ASTH
$1.77B
$1K ﹤0.01%
+101
New +$1.65K
CDMO
2227
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1K ﹤0.01%
331
-9,182
-97% -$55.6K
SMAR
2228
DELISTED
Smartsheet Inc.
SMAR
$1K ﹤0.01%
14
-153
-92% -$6.94K
PRMW
2229
DELISTED
Primo Water Corporation
PRMW
$1K ﹤0.01%
+136
New +$1.85K
PRFT
2230
DELISTED
Perficient Inc
PRFT
$1K ﹤0.01%
+42
New +$1.83K
GTHX
2231
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1K ﹤0.01%
103
-88
-46% -$1.64K
SBOW
2232
DELISTED
SilverBow Resources, Inc.
SBOW
$1K ﹤0.01%
550
-2,159
-80% -$10.6K
DSKE
2233
DELISTED
Daseke, Inc. Common Stock
DSKE
$1K ﹤0.01%
819
-51
-6% -$150
SRT
2234
DELISTED
Startek Inc.
SRT
$1K ﹤0.01%
+247
New +$1.65K
CORR
2235
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$1K ﹤0.01%
98
-7,490
-99% -$283K
ACER
2236
DELISTED
Acer Therapeutics Inc
ACER
$1K ﹤0.01%
669
-876
-57% -$3.21K
WWE
2237
DELISTED
World Wrestling Entertainment
WWE
$1K ﹤0.01%
+40
New +$1.94K
SURF
2238
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
568
-3,893
-87% -$10.3K
HARP
2239
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
+13
New +$1.83K
SRNE
2240
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1K ﹤0.01%
+623
New +$1.79K
ATNX
2241
DELISTED
Athenex, Inc. Common Stock
ATNX
$1K ﹤0.01%
8
-13
-62% -$3.27K
LCI
2242
DELISTED
Lannett Company, Inc.
LCI
$1K ﹤0.01%
55
-688
-93% -$23.1K
ELOX
2243
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$1K ﹤0.01%
18
-13
-42% -$2.12K
TEN
2244
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$1K ﹤0.01%
385
+379
+6,317% +$3.18K
LOGC
2245
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1K ﹤0.01%
+379
New +$2.95K
PHAS
2246
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$1K ﹤0.01%
+294
New +$1.35K
CHNG
2247
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$1K ﹤0.01%
148
+132
+825% +$1.85K
HMTV
2248
DELISTED
Hemisphere Media Group, Inc.
HMTV
$1K ﹤0.01%
117
+9
+8% +$112
MNDT
2249
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1K ﹤0.01%
56
+31
+124% +$446
WBT
2250
DELISTED
Welbilt, Inc.
WBT
$1K ﹤0.01%
187
-155
-45% -$1.86K

Similar funds

Meeder Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Meeder Asset Management held 2,725 positions worth $1.29B, down 21% from $1.64B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Meeder Asset Management's Q1 2020 filing shows 403 new, 995 increased, 859 reduced and 275 closed positions. Its largest new stake was Chimera Investment: 33,620 shares worth $916K. The largest sale was Xtrackers USD High Yield Corporate Bond ETF, an estimated $23.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Meeder Asset Management's largest Q1 2020 buy was Chimera Investment: 33,620 shares worth $916K.
  • Meeder Asset Management added most to Vanguard Short-Term Bond ETF in Q1 2020, an estimated $32.1M increase.
  • Meeder Asset Management's biggest Q1 2020 reduction was Xtrackers USD High Yield Corporate Bond ETF, cutting an estimated $23.8M.
  • Meeder Asset Management fully exited Dolby in Q1 2020, selling an estimated $775K.
  • Meeder Asset Management's ten largest holdings make up 27% of its $1.29B portfolio in Q1 2020.
  • Meeder Asset Management opened 403 new positions and closed 275 in Q1 2020.
  • Meeder Asset Management's portfolio value fell 21% quarter-over-quarter to $1.29B.

Based on Meeder Asset Management's 13F filing for Q1 2020, filed 15 May 2020.